AARD (STOCKS)
Aardvark Therapeutics, Inc. Common Stock
$6.410000
-0.160000 (-2.44%)
Prev close: $6.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tien Li Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $139.84M
- Employees
- 31
- P/E (TTM)
- -2.05
- P/B (TTM)
- 1.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.99 | $-0.89 | -0.0952 | -10.64% |
|
Dec 2025 (Q4)
|
$-0.81 | $-0.85 | +0.0394 | +4.64% |
|
Sep 2025 (Q3)
|
$-0.75 | $-0.81 | +0.0645 | +7.92% |
|
Jun 2025 (Q2)
|
$-0.66 | $-0.61 | -0.0480 | -7.84% |
Financial Statements
| Revenues | $1.35M |
| Nonoperating Income/Loss | $4.07M |
| Operating Expenses | $73.96M |
| Research and Development | $55.06M |
| Other Operating Expenses | $18.90M |
| Operating Income/Loss | -$73.96M |
| Income/Loss From Continuing Operations After Tax | -$69.89M |
| Income/Loss From Continuing Operations Before Tax | -$52.22M |
| Interest And Dividend Income, Operating | $4.06M |
| Net Income/Loss | -$69.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$69.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$69.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.21 |
| Diluted Earnings Per Share | -$3.21 |
| Basic Average Shares | 44,272,201 |
| Diluted Average Shares | 44,272,201 |
| Assets | $81.46M |
| Current Assets | $80.66M |
| Cash | $73.90M |
| Other Current Assets | $6.76M |
| Noncurrent Assets | $799.00K |
| Liabilities | $6.66M |
| Current Liabilities | $6.39M |
| Accounts Payable | $2.09M |
| Wages | $2.16M |
| Other Current Liabilities | $2.14M |
| Noncurrent Liabilities | $276.00K |
| Equity | $74.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $74.80M |
| Liabilities And Equity | $81.46M |
| Net Cash Flow From Operating Activities | -$69.41M |
| Net Cash Flow From Operating Activities, Continuing | -$69.41M |
| Net Cash Flow From Investing Activities | $116.55M |
| Net Cash Flow From Investing Activities, Continuing | $116.55M |
| Net Cash Flow From Financing Activities | $711.00K |
| Net Cash Flow From Financing Activities, Continuing | $711.00K |
| Net Cash Flow | $47.85M |
| Net Cash Flow, Continuing | $47.85M |
| Comprehensive Income/Loss | -$69.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$69.89M |
| Other Comprehensive Income/Loss | -$69.89M |